Related Experiment Video
Updated: Jun 6, 2025

Scanning Electron Microscopy of Macerated Tissue to Visualize the Extracellular Matrix
Published on: June 14, 2016
Pericardial Fluid of Patients With Coronary Artery Disease Can Drive Fibrosis Via TGF-Beta Pathway
Ali Fatehi Hassanabad1,2, Darrell D Belke2, Paul M K Gordon3
1Section of Cardiac Surgery, Department of Cardiac Sciences, Libin Cardiovascular Institute, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.
Insights
Human pericardial fluid (PF) contains active markers that stimulate cardiac fibroblast activity via the transforming growth factor-beta pathway. This profibrotic capacity is elevated in patients with coronary artery disease.
Area of Science:
- Cardiovascular biology
- Fibrosis research
- Biomarker discovery
Background:
- Human pericardial fluid (PF) is a source of biologically active molecules.
- Pericardial fluid influences cardiac cell behavior.
- Transforming growth factor-beta (TGF-β) is a key regulator of fibrosis.
Purpose of the Study:
- To investigate the role of acellular human pericardial fluid in cardiac fibroblast activation.
- To identify the molecular pathways involved in PF-mediated fibroblast activity.
- To compare the profibrotic capacity of PF from patients with and without coronary artery disease (CAD).
Main Methods:
- In vitro assays using cardiac fibroblasts.
- Analysis of acellular pericardial fluid.
- Assessment of transforming growth factor-beta pathway activation.
Main Results:
- The acellular component of human pericardial fluid promotes cardiac fibroblast activity in vitro.
- This activation is mediated by the transforming growth factor-beta pathway.
- Pericardial fluid from patients with coronary artery disease exhibits a significantly higher profibrotic capacity compared to that from control patients.
Conclusions:
- Human pericardial fluid possesses intrinsic profibrotic properties.
- The transforming growth factor-beta pathway is a critical mediator of PF-induced cardiac fibroblast activation.
- Elevated profibrotic capacity of pericardial fluid in coronary artery disease patients may contribute to cardiac remodeling.
Abstract:
Human pericardial fluid (PF) is a rich reservoir of biologically active markers. The acellular compartment of PF can drive cardiac fibroblast activity in vitro. This process is mediated through the transforming growth factor-β pathway. Of clinical importance, the PF of patients with coronary artery disease has an increased profibrotic capacity compared with the PF of patients without coronary artery disease.
Related Concept Videos
Pericarditis I: Introduction
Rheumatic Heart Disease I: Introduction
Myocarditis I: Introduction
Pathophysiology of Heart Failure
Pericarditis IV: Nursing Management
Pericarditis II: Clinical features and Diagnostic Tests

